Egis, Gornictwo, KGHM, Pekao May Be Active: Central Europe Stock Preview

The following is a list of companies whose shares may have unusual price changes in central European markets. Stock symbols are in parentheses after company names. Share prices are from the last close.

Poland’s WIG20 Index gained 1.4 percent, the Czech PX Index advanced 0.7 percent and Hungary’s BUX Index added 0.9 percent.

Egis Nyrt. (EGIS HB): The Hungarian drugmaker owned by Laboratoires Servier said third-quarter net income surged more than fivefold to 2.8 billion forint ($14.1 million), or 359 forint a share, from 531 million forint, or 68 forint per share in the same period last year, as pre-shipments to Russia boosted sales. Sales rose 23 percent to 32.4 billion forint. Egis gained 0.5 percent to 22,450 forint.

KGHM Polska Miedz SA (KGH PW): The copper producer with the biggest European mine output is scheduled to release third- quarter earnings. KGHM jumped 7.4 percent to 144 zloty.

Bank Pekao SA (PEO PW): Poland’s second-largest bank as well as financial-services company Getin Holding SA (GTN PW) and ING Bank Slaski SA (BSK PW) report third-quarter earnings. Pekao climbed 2.1 percent to 196.5 zloty, Getin fell 1.3 percent to 11.1 zloty and Slaski increased 1.1 percent to 908 zloty.

Polskie Gornictwo Naftowe i Gazownictwo SA (PGN PW): Poland’s biggest natural gas distributor will release third- quarter results. Its shares added 0.5 percent to 3.87 zloty.

Tauron Polska Energia SA (TPE PW): Poland’s second-largest utility will join the Warsaw Stock Exchange’s benchmark WIG20 Index after the Dec. 17 trading session, replacing Bioton SA (BIO PW), Poland’s largest biotechnology company. Tauron rose 1.1 percent to 6.64 zloty, while Bioton slid 5.3 percent to 0.18 zloty.

To contact the reporters on this story: Pawel Kozlowski in Warsaw pkozlowski@bloomberg.net; Monika Rozlal in Warsaw at mrozlal@bloomberg.net

To contact the editor responsible for this story: Gavin Serkin at gserkin@bloomberg.net

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.